The clinical and molecular effects of an insulin sensitizing drug 'pioglitazone' on treatment of psoriasis /
Vanessa Suzan Galal Aly Hafez
The clinical and molecular effects of an insulin sensitizing drug 'pioglitazone' on treatment of psoriasis / المفعول الإكلينيكي و الجزيئي للدواء المحسس الانسولين "بيوجليتازون" في علاج الصدفية Vanessa Suzan Galal Aly Hafez ; Supervised Manal A. W. Bosseila , Mohamed I. Sheta , Mona R. E. Abdelhalim - Cairo : Vanessa Suzan Galal Aly Hafez , 2011 - 178 P. : charts , facsimiles ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Dermatology and Venerology
Psoriasis has been viewed recently as a multisystem disease with several important comorbidities such as: metabolic symdrome, insulin resistance and increased cardiovascular risk. All share common inflammatory pathogenic mechanisms. Pioglitazone, a peroxisome proliferator activated receptor-gamma (PPAR y) agonist
Pioglitazone Psoriasis Randomized controlled trial
The clinical and molecular effects of an insulin sensitizing drug 'pioglitazone' on treatment of psoriasis / المفعول الإكلينيكي و الجزيئي للدواء المحسس الانسولين "بيوجليتازون" في علاج الصدفية Vanessa Suzan Galal Aly Hafez ; Supervised Manal A. W. Bosseila , Mohamed I. Sheta , Mona R. E. Abdelhalim - Cairo : Vanessa Suzan Galal Aly Hafez , 2011 - 178 P. : charts , facsimiles ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Dermatology and Venerology
Psoriasis has been viewed recently as a multisystem disease with several important comorbidities such as: metabolic symdrome, insulin resistance and increased cardiovascular risk. All share common inflammatory pathogenic mechanisms. Pioglitazone, a peroxisome proliferator activated receptor-gamma (PPAR y) agonist
Pioglitazone Psoriasis Randomized controlled trial